Details of Host Protein
Host Protein General Information (ID: PT1242) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
Vesicular glutamate transporter 2 (MAP4K4)
|
Gene Name |
SLC17A6
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
VGLU2_HUMAN
|
||||||
Protein Families |
Major facilitator superfamily
|
||||||||
Subcellular Location |
Cytoplasmic vesicle; secretory vesicle; synaptosome
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
Mediates the uptake of glutamate into synaptic vesicles atpresynaptic nerve terminals of excitatory neural cells. May also mediate the transport of inorganicphosphate. Involved in the regulation of retinalhyaloid vessel regression during postnatal development.
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
Nicotine addiction | hsa05033 | Pathway Map | |||||||
Synaptic vesicle cycle | hsa04721 | Pathway Map | |||||||
Retrograde endocannabinoid signaling | hsa04723 | Pathway Map | |||||||
Glutamatergic synapse | hsa04724 | Pathway Map | |||||||
Nicotine addiction | hsa05033 | Pathway Map | |||||||
Synaptic vesicle cycle | hsa04721 | Pathway Map | |||||||
Retrograde endocannabinoid signaling | hsa04723 | Pathway Map | |||||||
Glutamatergic synapse | hsa04724 | Pathway Map | |||||||
3D Structure |
|
Function of This Protein During Virus Infection | |||||||||
---|---|---|---|---|---|---|---|---|---|
Virus Name | SARS-COV-2 | Protein Function | Pro-viral | [1] | |||||
Infected Tissue | Lung | Infection Time | 7-9 Days | ||||||
Infected Cell | Calu-3 Cells (Human epithelial cell line) | Cellosaurus ID | CVCL_0609 | ||||||
Method Description | To detect the role of host protein SLC17A6 in viral infection, SLC17A6 protein knockout Calu-3 Cells were infected with SARS-COV-2 for 7 - 9 Days , and the effects on infection was detected through CRISPR-based genome-wide gene-knockout screen. | ||||||||
Results | It is reported that knockout of SLC17A6 leads to the decreased SARS-CoV-2 RNA levels compared with control group. |
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: 3'-UTR (hCoV-19/Wuhan-Hu-1/2019 ) | |||||||||
RNA Region Details | RNA Info Click to show the detail information of this RNA binding region | [2] | |||||||
Strains Name |
hCoV-19/Wuhan-Hu-1/2019
|
||||||||
Strains Family |
Beta (B.1.351)
|
||||||||
RNA Binding Region |
3'-UTR
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | HEK293 Cells (Human embryonic kidney cell) (CVCL_0045 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Infection Time | 48 h | ||||||||
Interaction Score | Prot score = 29 | ||||||||
Method Description | RNA-protein interaction detection (RaPID) assay; liquid chromatography with tandem mass spectrometry (LC-MS/MS) |